Remote Cognitive Screening in Parkinson Disease: Validating the ORCA-PD Tool
Parkinson disease (PD) is predominantly recognized for its motor symptoms, yet covert cognitive decline affects many patients long before dementia occurs. Traditional in-person cognitive testing presents substantial barriers: severe mobility impairments make traveling to clinics difficult, expert evaluations suffer from long waitlists, and screening tools like the Montreal Cognitive Assessment (MoCA) rely heavily on fine motor tasks like drawing, which can confound cognitive scores.
